Results 251 to 260 of about 100,511 (312)
Marked QTc Interval Prolongation Associated With Dronedarone in Paroxysmal Atrial Fibrillation and No Structural Disease. [PDF]
CureusHernandez Mejia S +3 more
europepmc +1 more source
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs
New England Journal of Medicine, 2016 George A Wells +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Cardiology, 1991
Medically refractory tachyarrhythmias remain a significant clinical problem. The indications for surgical intervention in this challenging patient population continue to expand. Advances in noninvasive detection of patients at risk, as well as expanding electrophysiologic testing, continue to help define patients best served by surgical therapy ...
M A, Grosso, A H, Harken
openaire +2 more sources
Medically refractory tachyarrhythmias remain a significant clinical problem. The indications for surgical intervention in this challenging patient population continue to expand. Advances in noninvasive detection of patients at risk, as well as expanding electrophysiologic testing, continue to help define patients best served by surgical therapy ...
M A, Grosso, A H, Harken
openaire +2 more sources
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia
New England Journal of MedicineBACKGROUND Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tachycardia.
Jeff S Healey +2 more
exaly +2 more sources
Current Treatment Options in Cardiovascular Medicine, 2004
Both supraventricular and ventricular arrhythmias are associated with increased mortality and morbidity. Numerous antiarrhythmics have been developed in an attempt to decrease the frequency of these arrhythmias, hoping to improve survival and improve quality of life.
Steven N., Singh +2 more
openaire +2 more sources
Both supraventricular and ventricular arrhythmias are associated with increased mortality and morbidity. Numerous antiarrhythmics have been developed in an attempt to decrease the frequency of these arrhythmias, hoping to improve survival and improve quality of life.
Steven N., Singh +2 more
openaire +2 more sources
Antiarrhythmic Drugs: Risks and Benefits.
The Medical clinics of North America, 2019The narrow therapeutic window of antiarrhythmic drugs makes their use clinically challenging. A solid understanding of the mechanisms of arrhythmias and how antiarrhythmics affect these mechanisms is only a preliminary step in their appropriate selection.
P. Mankad, G. Kalahasty
semanticscholar +1 more source